E2B Per Year
| Year | E2B |
|---|---|
| 2024 | 3 |
| Total | 3 |
|---|
E2B per Month
| Month | E2B |
|---|---|
| Aug 2024 | 1 |
| Sep 2024 | 1 |
| Oct 2024 | 1 |
| Total | 3 |
|---|
E2B per Company
| Company | E2B |
|---|---|
| Pfizer | 1 |
| Glaxosmithkline | 1 |
| Ethypharm | 1 |
| Total | 3 |
|---|
| Year | E2B |
|---|---|
| 2024 | 3 |
| Total | 3 |
|---|
| Month | E2B |
|---|---|
| Aug 2024 | 1 |
| Sep 2024 | 1 |
| Oct 2024 | 1 |
| Total | 3 |
|---|
| Company | E2B |
|---|---|
| Pfizer | 1 |
| Glaxosmithkline | 1 |
| Ethypharm | 1 |
| Total | 3 |
|---|